Teva Strengthens its Position in the US and Spanish Markets
Sally Mardikian PhD
Abstract
Teva has entered into one of its biggest deals with the acquisition of US generics giant, Barr Pharmaceuticals, and completed the purchase of Bentley Pharmaceuticals in Spain - substantially increasing its product portfolio both in the US and European markets.
Full Text: pdf html
Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.